Short answer · Medically reviewed summary · Last updated: 2026-04-06
Progressive Supranuclear Palsy (PSP) is a rare, neurodegenerative brain disorder that progressively damages nerve cells in areas of the brain that control balance, movement, vision, speech, and swallowing. Understanding the Condition As a specialist physician, I describe Progressive Supranuclear Palsy as a "tauopathy," meaning it is caused by the abnormal accumulation of a protein called tau within the brain. This protein buildup leads to the gradual deterioration of cells in the brainstem and basal ganglia, which are critical for coordinating complex movements.
1 people with Progressive Supranuclear Palsy have shared their first-person experience on this question at DiseaseMaps.
What is Progressive Supranuclear Palsy
What is Progressive Supranuclear Palsy? Plain-language, medically reviewed definition plus the lived reality told by patients.
Progressive Supranuclear Palsy (PSP) is a rare, neurodegenerative brain disorder that progressively damages nerve cells in areas of the brain that control balance, movement, vision, speech, and swallowing.
Understanding the Condition
As a specialist physician, I describe Progressive Supranuclear Palsy as a "tauopathy," meaning it is caused by the abnormal accumulation of a protein called tau within the brain. This protein buildup leads to the gradual deterioration of cells in the brainstem and basal ganglia, which are critical for coordinating complex movements. While Progressive Supranuclear Palsy shares some symptoms with Parkinson’s disease, it is a distinct clinical entity that usually progresses more rapidly and involves different areas of the brain.
Affected Systems and Symptoms
The primary system affected is the central nervous system. Patients frequently experience early-onset postural instability, leading to frequent falls. A hallmark feature of Progressive Supranuclear Palsy is vertical supranuclear gaze palsy, which is the specific inability to move the eyes downward or upward voluntarily. Additionally, the disease affects the motor control of the mouth and throat, often resulting in slurred speech (dysarthria) and difficulty swallowing (dysphagia), which requires careful management to prevent aspiration.
Prevalence and Demographics
Progressive Supranuclear Palsy is considered a rare disease, with an estimated prevalence of approximately 5 to 6 per 100,000 individuals. It typically affects adults, with the average age of onset occurring in the early 60s. While it is seen slightly more often in men than women, it affects individuals globally across all ethnic and geographic backgrounds. There is no known environmental or lifestyle trigger that causes the condition, and it is generally considered a sporadic disorder rather than an inherited one.
Clinical Differentiation
Unlike Parkinson’s disease, where tremors are common, Progressive Supranuclear Palsy is characterized by a "stiff" posture and a tendency to fall backward. Personality changes, such as apathy or impulsivity, are also more common in the early stages of this condition compared to other parkinsonian syndromes.
Disclaimer: This information is for educational purposes and should not replace professional medical advice, diagnosis, or treatment. Always seek the advice of your neurologist or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- CurePSP: Foundation for PSP and CBD
- Orphanet: The portal for rare diseases and orphan drugs
Posted Sep 24, 2021 by matina 2610
